期刊文献+

MR对非酒精性脂肪肝的评价 被引量:4

Evaluation study of MRI on non-alcoholic fatty liver disease
下载PDF
导出
摘要 目的:评价MRI对非酒精性脂肪肝(NAFLD)的价值。方法:45例肥胖患者行MR T1dual和1H-MRS检查,评价这两种方法计算NAFLD含量临界值的意义,并与CT检查作对照。结果:MR T1dual HFF、RSID及1H-MRS等方法与CT评价脂肪肝程度的相关系数分别为-0.951、-0.935、-0.659(P<0.01)。且各种评价方法分别与TG、GGT指标显著相关,其中RSID与TG、GGT相关性最好(r=0.406、0.457,P<0.01),而1H-MRS所评价的肝内脂质含量分别与ALT、TG及GGT之间有对数的线性关系。结论:MRI T1dual是一种方便、快速、安全的定量检查NAFLD方法,HFF9%、RSID 20%可作为有无肝内脂肪浸润的指标。MR T1dual中RSID及1H-MRS可以很好的评价肝内TG水平。 Objective:To evaluate the clinical value of MRI on non-alcoholic fatty liver disease(NAFLD).Methods:Forty-five obesity patients underwent in-phase/opposed-phase(IP/OP) magnetic resonance imaging and 1H-magnetic resonance spectroscopy(1H-MRS),we try to find the cut-off point of NAFLD detected by MRI according to the hepatic steatosis severity by CT.Results:Compared with CT,the coefficient correlation of IP/OP MRI hepatic fat fraction(HFF),relative signal intensity decrease(RSID) by MRI and intrahepatocellular lipids of 1H-MRS were-0.951,-0.935,-0.659(P〈0.01).The hepatic steatosis severity of all methods above were significantly correlate with TG and GGT.In which,RSID was the most correlated parameter(r=0.406,0.457,P〈0.01).Linear regression analysis was conducted on a log-log scale among the 1H-MRS and ALT,TG and GGT.Conclusion:IP/OP MRI is a convenient,fast,and safe technique,which can detect and quantify liver steatosis.A diagnosis of fatty liver was established with HFF≥9%,RSID≥20%.RSID criterion and intrahepatocellular lipids of ^1H-MRS facilitated the correct prediction of the concentration of TG.
出处 《放射学实践》 北大核心 2010年第6期642-645,共4页 Radiologic Practice
基金 上海市重点学科建设项目资助(S30203)
关键词 肥胖症 脂肪肝 代谢综合征 磁共振成像 Obesity Fatty liver Metabolic syndrome Magnetic resonance imaging
  • 相关文献

参考文献9

  • 1Neuschwander-Tetri BA.Fatty liver and the metabolic syndrome[J].Curr Opin Gastroenterol,2007,23(2):193-198.
  • 2Sanyal AJ,AGA.AGA technical review on nonalcoholic fatty liver disease[J].Gastroenterology,2002,123(5):1705-1725.
  • 3Merkle EM,Nelson RC.Dual gradient-echo in-phase and opposed-phase hepatic MR imaging:a useful tool for evaluating more than fatty infiltration or fatty sparing[J].Radiographics,2006,26(5):1409-1418.
  • 4Pacifico L,Celestre M,Anania C,et al.MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease[J].Acta paediatr,2007,96(4):542-547.
  • 5Fishbein MH,Mogren C,Gleason T,et al.Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease[J].J Pediatr Gastroenterol Nutr,2006,42(1):83-88.
  • 6Kim SH,Lee JM,Han JK,et al.Hepatic macrosteatosis:predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings[J].Radiology,2006,240(1):116-112.
  • 7Tanoli T,Yue P,Yablonskiy D,et al.Fatty liver in familial hypobetalipoproteinemia:roles of the APOB defects,intra-abdominal adipose tissue and insulin sensitivity[J].J Lipid Res,2004,45(5):941-947.
  • 8Thomas EL,Hamilton G,Patel N,et al.Hepatic triglyceride content and its relation to body adiposity:a magnetic resonance imaging and proton magnetic resonance spectroscopy study[J].Gut,2005,54(1):122-127.
  • 9Machann J,Thamer C,Schnoedt B,et al.Hepatic lipid accumulation in healthy subjects:a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy[J].Magnetic Resonance in Medicine,2006,55(4):913-917.

同被引文献32

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):43-48. 被引量:469
  • 2陈麦林,曾庆玉,许惠敏,霍建伟,尹晓明,李宝平,刘建新,黄曼维.3.0T MR波谱技术在非酒精性脂肪肝中的临床应用[J].中国医学影像技术,2009,25(S1):99-101. 被引量:6
  • 3郑瑞丹,陆伦根,孟家榕,黄俊达,饶日春,徐成润,曾民德.非酒精性脂肪性肝病临床和病理学研究[J].中华肝脏病杂志,2006,14(6):449-452. 被引量:26
  • 4Lidofsky SD. Nonalcoholic fatty liver disease: diagnosis and rela- tion to metabolic syndrome and approach to treatment [J]. Curt"DiabRep, 2008, 8 (1): 25-30.
  • 5Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents[J]. Pediatrics, 2006, 118 (4) : 1388-1393.
  • 6Trak-Smayra V, Dargere D, Noun R, et al. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery [J]. Gut, 2009, 58 (6): 825- 832.
  • 7Fan JG, Saibara T, Chitturi S, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific [J. J Gastroenterol Hepatol, 2007, 22 (6): 794-800.
  • 8Huang P, Lo LH, Chen YC, et al. Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke [J]. J Neurol, 2009, 256 (4): 625-631.
  • 9Yu Chaohui, Xa Chengfu, Lei Xu, et al. Serum proteomic analy- sis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease[J]. J Hepatol, 2012, 56 (1): 241-247.
  • 10Mahr N, Neyer U, Prischl F, et al. Proteinuria and hemoglobin levels in patients with primary glomerular disease[J]. Am J Kidney Dis, 2005, 46 (3): 424-431.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部